))
Olympus scopes in Class I recall could cause burns; BioTelemetry settles false claims allegations
Manage episode 390747710 series 3481361
Content provided by Fast Five by MassDevice. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fast Five by MassDevice or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 21, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Pulse Biosciences announced the first human use of its pulsed-field ablation catheter. Fast Five hosts Danielle Kirsh and Sean Whooley discuss how the catheter works and what performing doctors thought about using the device. Henry Schein is entering the orthopedic extremities market by acquiring a majority interest in TriMed. Whooley talks about how the deal helps Henry Schein and some of the company's other news from this year. Zoll Medical has disclosed an email phishing attack and potential data breach at the company. Hear what caused the attack and details about whether information as been misused in today's podcast. Philips' BioTelemetry will pay $14.7 million to settle false claims violation allegations, the U.S. Department of Justice has said. The Fast Five hosts go over the allegations and what the DOB contended. Olympus bronchoscopes in a Class I recall could lead to burns and fires. Whooley explains which devices are affected, what could happen with continued use and what the company is recommending.
…
continue reading
161 episodes
Share
